CBD Life Sciences Inc. (CBDL) Gears Up for Cave Creek Bike Week 2025
CBDL Targets a Multi-Million Dollar Market as Tens of Thousands of Attendees Converge for Arizona's Hottest Motorcycle Event
SCOTTSDALE, AZ / ACCESS Newswire / March 25, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a market leader in the CBD and mushroom wellness industry, is revving up for its high-octane presence at the legendary Cave Creek Bike Week, March 28 - April 6, 2025. With tens of thousands of motorcycle enthusiasts and thrill-seekers converging on Cave Creek, this premier event presents an unparalleled opportunity for CBDL to showcase its groundbreaking product line, maximize brand visibility, and generate explosive revenue growth.
Cave Creek Bike Week, hosted by the Hideaway Grill and Roadhouse, has become a nationally recognized gathering of riders, industry professionals, and lifestyle brands. The 2024 event boasted record attendance, featuring jaw-dropping stunt shows, live music, exclusive vendors, and premium entertainment. The Hideaway Grill is located at 6746 E Cave Creek Rd, Cave Creek, AZ 85331.
While exact figures for Cave Creek Bike Week remain undisclosed, it coincides with Arizona Bike Week, which reported an astonishing 85,000 attendees in 2023. With attendees typically spending hundreds of dollars per visit on lifestyle and wellness products, this event represents a major revenue catalyst for participating businesses. Estimates suggest that Arizona Bike Week alone generates upwards of $20 million in local economic impact, a number that underscores the lucrative potential for vendors like CBDL. By tapping into this high-spending demographic, CBDL is strategically positioned to capitalize on the surging demand for premium wellness solutions.
CBDL's subsidiary, Mushroom Madness, will take center stage with a high-visibility tent at the Horny Toad Restaurant, located at 6738 E Cave Creek Rd, Cave Creek, AZ 85331. This prime location ensures maximum foot traffic and engagement, giving attendees direct access to an exclusive selection of CBDL's cutting-edge products, including:
3000MG CBD Pain Relief Cream - A best-seller now featured on Walmart Marketplace, designed to deliver fast, long-lasting relief for muscle and joint pain.
Mellow Mornings CBD Coffee Creamer - A revolutionary nano-CBD infused creamer providing up to 10x bioavailability for stress-free mornings.
Functional Mushroom Supplements - Featuring Reishi, Lion's Mane, and Ashwagandha, formulated to enhance cognitive function, reduce stress, and support immunity.
Kava & Kratom Energy Shots - A breakthrough in plant-based energy and relaxation, catering to alternative wellness enthusiasts.
'We see Cave Creek Bike Week as a monumental revenue driver and a launchpad for even greater market penetration,' said Lisa Nelson, CEO of CBD Life Sciences Inc. 'This event places us directly in front of a massive consumer base that aligns perfectly with our brand - people who prioritize performance, endurance, and natural wellness. With our growing presence in retail and e-commerce, this is the perfect moment for investors to take notice of CBDL's rapid expansion.'
CBDL's participation aligns with its aggressive growth strategy, leveraging high-traffic events to drive direct-to-consumer sales, brand loyalty, and shareholder value. With increasing product adoption and expanding retail partnerships, the company is poised for continued revenue acceleration in 2025.
For more information about CBD Life Sciences Inc. and its participation in Cave Creek Bike Week, please visit www.thecbdvault.com
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) is an industry leader in health and wellness, specializing in premium CBD and functional mushroom-based products. Through its subsidiaries, including Mushroom Madness, the company provides high-quality, scientifically formulated wellness solutions designed to enhance daily life. With a commitment to innovation, expansion, and shareholder growth, CBDL continues to push boundaries in the rapidly evolving alternative wellness market.
Note: The attendance figures mentioned pertain to Arizona Bike Week and are provided for contextual purposes. Actual attendance at Cave Creek Bike Week may vary.
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
CEO
4802091720
SOURCE: CBD Life Sciences, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Sylla Gold Announces Loans
Bedford, Nova Scotia--(Newsfile Corp. - June 6, 2025) - Sylla Gold Corp. (TSXV: SYG) (OTC Pink: SYGCF) ("Sylla" or the "Company") announces it has issued unsecured promissory notes (the "Notes") in the principal amount of $45,000 in connection with the loans (the "Loans") to the Company from non arm's length and arm's length lenders (collectively, the "Lenders"). The Notes bear interest at seven percent (7%) per annum and the Loans and any accrued interest owing pursuant to the Notes, shall become due and be paid in full on demand, which demand may be made by the Creditor at any time after June 6, 2026. In connection with the Notes, the Company will issue to the Lenders an aggregate of 599,998 common shares (each, a "Common Share") in the capital of the Company at a deemed price of $0.015 per Common Share as a loan bonus. The Company intends to use the net proceeds from the Loans for: (i) approximately $36,000 for the audit for the financial year ended February 28, 2024; (ii) approximately $4,000 to the Company's transfer agent, for services rendered; and (iii) approximately $5,000 for general working capital purposes. All Common Shares issued in connection with the Notes will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation. The issuance of the Common Shares remains subject to receipt of all necessary corporate and regulatory approvals, including the approval of the TSX Venture Exchange. The issuance of the Notes constitutes a related party transaction within the meaning of TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101") as certain Lenders are directors and/or officers of the Company. The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(b) and 5.7(1)(a) of MI 61-101, as the Company is not listed on a specified market and the principal amount of the Notes held by the insiders do not exceed 25% of the market capitalization of the Company in accordance with MI 61-101. The Company did not file a material change report more than 21 days before the issuance of the Notes as the Company wished to close on an expedited basis. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons as defined under applicable United States securities laws unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. For more information, please contact: Regan IsenorPresident and Chief Executive OfficerTel: (902) 233-4381Email: risenor@ Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release contains certain "forward-looking information" within the meaning of applicable securities laws. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Indianapolis Star
2 days ago
- Indianapolis Star
Divorced and Facing IRS Collection? Clear Start Tax Outlines How Innocent Spouse Relief Could Save You Thousands
Clear Start Tax Explains How Divorced Taxpayers Can Escape IRS Liability for a Former Spouse's Mistakes IRVINE, CA / ACCESS Newswire Divorce can be complicated enough without the added stress of IRS debt. Yet every year, countless divorced Americans are shocked to discover they're on the hook for a former spouse's tax liabilities – often for mistakes they didn't know about. According to Clear Start Tax, a leading national tax resolution firm, the IRS's Innocent Spouse Relief program can offer a powerful – and often overlooked – solution. When Divorce Leaves Taxpayers Facing a Former Spouse's Mistakes Many taxpayers assume that a divorce decree automatically separates their financial obligations. But under joint tax returns, the IRS can pursue either spouse for the full amount owed, including taxes, penalties, and interest. That means years after a divorce, one spouse may face wage garnishment, bank levies, or collection notices for a tax bill they had no role in creating. 'We've worked with clients blindsided by IRS letters years after their divorce,' said the Head of Client Solutions at Clear Start Tax. 'Innocent Spouse Relief can be a lifeline in these cases – but most people don't even realize it exists.' Who Qualifies for Innocent Spouse Relief? Clear Start Tax explains that the IRS looks at several key factors when reviewing Innocent Spouse claims: The tax understatement was due to the other spouse's error (such as unreported income or inflated deductions). The innocent spouse didn't know, and had no reason to know, about the issue at the time. Holding the innocent spouse liable would be unfair or create hardship. The innocent spouse applies within the IRS's filing window (generally two years from first collection notice). Why the Right Approach Is Essential for Approval While the program offers powerful protection, Clear Start Tax emphasizes that success depends on a careful application and thorough documentation. Missing deadlines, submitting incomplete paperwork, or misunderstanding eligibility rules can lead to denial, leaving taxpayers exposed to the full debt. 'Innocent Spouse Relief isn't just a form-it's a carefully built case,' said the Head of Client Solutions at Clear Start Tax. 'We work closely with our clients to present the strongest possible application, so they can move forward without being burdened by a former partner's tax mistakes.' How Clear Start Tax Helps Divorced Taxpayers Regain Control Clear Start Tax offers a hands-on, strategic approach to Innocent Spouse claims and other tax resolution programs: Comprehensive case reviews to assess eligibility and strengthen claims Detailed preparation of IRS applications with supporting evidence Direct IRS communication and negotiation on the client's behalf Post-resolution guidance to maintain compliance and peace of mind About Clear Start Tax Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm's unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry. Need Help With Back Taxes? Click the link below: Contact Information Clear Start Tax Corporate Communications Department seo@ (949) 535-1627 SOURCE: Clear Start Tax View the original press release on ACCESS Newswire
Yahoo
2 days ago
- Yahoo
PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing
Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic collaboration with Commonwealth, the syndicated ownership group behind 2023 Kentucky Derby winner Mage, and 2022 Dubai World Cup Champion Country Grammer. The partnership centers on the clinical use and promotion of SPRYNG® with OsteoCushion® Technology, PetVivo's cutting-edge intra-articular device designed to support joint health and durability, and Precise PRP™, a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians in elite equine athletes. As part of this collaboration, Commonwealth intends to integrate SPRYNG and PrecisePRP, when possible, into the care protocols of its top-tier thoroughbred stable, using the technology as both a preventative measure and a treatment solution to promote joint health, extend performance longevity, and support recovery in high-impact training and racing environments. In addition to clinical implementation, PetVivo and Commonwealth will explore co-branded content, educational initiatives, and industry outreach designed to elevate awareness around joint wellness and support broader adoption of SPRYNG and PrecisePRP across the equine health community. John Lai, CEO of PetVivo, commented, "Partnering with Commonwealth, a proven leader in the highest levels of the sport, marks a major milestone for SPRYNG and PrecisePRP. Their championship-caliber horses and progressive approach to wellness makes them the ideal partner to showcase the benefits of our technology. Together, we're advancing a shared vision of equine health that emphasizes performance, longevity, and science-backed care." Chase Chamberlin, CEO of Commonwealth, stated, 'At Commonwealth, our mission is to champion our equine athletes on and off the track. With HISA's new welfare protocols raising the bar for horse safety, SPRYNG and PrecisePRP are game‑changing advances in preventive and rehabilitative joint care. This partnership allows us to push the boundaries of equine medicine, while minimizing injury risk and downtime, so our horses can perform at their best. We're proud to join forces with PetVivo to deliver cutting‑edge treatments that safeguard the health and future of our champions.' Mike Eldred, Board Director at PetVivo, commented, 'We are excited to join forces with Commonwealth in advancing the clinical use of SPRYNG and Precise PRP. This partnership represents a significant step forward in our commitment to being the market leader in equine joint health and regenerative medicine. By combining PetVivo's clinical expertise and commercial capabilities, with Commonwealth's equine industry knowledge and network, we aim to provide veterinarians with cutting-edge, effective solutions that enhance recovery and long-term soundness in competitive horses.' About Commonwealth Commonwealth is a leading investment platform that allows fans to buy equity shares in thoroughbred racehorses starting at $50 per share. Dedicated to providing thrilling fan experiences that create lifelong memories and bring them closer than ever to the sport, Commonwealth campaigned 2023 Kentucky Derby winner Mage and the world's highest earning racehorse of 2022, Country Grammer. Learn more and download the app here. About PetVivo Holdings, Inc. PetVivo Holdings Inc. (OTCQB: PETV; OTCPINK: PETVW) is a biomedical device company focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. PetVivo has a portfolio of twelve patents and six proprietary trade secrets that protect the company's biomaterials, products, production processes and methods of use. The company's lead products SPRYNG, is a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. The company recently launched PrecisePRP, a first-in-class, off-the-shelf, allogenic, platelet-rich plasma (PRP) product. For more information about PetVivo Holdings, Inc. and our revolutionary products, Spryng and PrecisePRP, please contact info1@ or visit or Contact Information:John Lai, CEOPetVivo Holdings, info1@ 405-6216 Forward-Looking Statements: The foregoing material may contain 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company's proposed development and commercial timelines, and can be identified by the use of words such as 'may,' 'will,' 'expect,' 'project,' 'estimate,' 'anticipate,' 'plan,' 'believe,' 'potential,' 'should,' 'continue' or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to PetVivo and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the PetVivo's business are described in detail in PetVivo's Annual Report on Form 10-K for the year ended March 31, 2024, and other periodic and current reports filed with the Securities and Exchange Commission. PetVivo is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
